BRIEF

on DIAGNOSTIC MEDICAL (EPA:ALDMS)

Strategic agreement between DMS Group, InnoLux and InnoCare

Stock price chart of DIAGNOSTIC MEDICAL (EPA:ALDMS) showing fluctuations.

DMS Group, a European medical imaging specialist, has signed an agreement in principle with InnoLux Corporation and its subsidiary InnoCare Optoelectronics. This commitment marks the beginning of a strategic partnership in the field of medical imaging. InnoLux, a major electronics company based in Taiwan, will invest up to €10 million, with an initial tranche of €2 million. The shares will be issued at €1.19, representing a 12% premium to the six-month average share price.

The goal of this partnership is to propel DMS Group as a leading European platform for medical imaging. Strengthening competitiveness through InnoLux technologies is a priority. However, the finalization of this agreement remains conditional, and the details of the next steps remain to be determined.

R. P.

Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all DIAGNOSTIC MEDICAL news